Feed PGNY
PG

Progyny, Inc. PGNY · NASDAQ

$27.84 +3.65% (+$0.98)

Market cap
$2.06B
Enterprise value
$1.94B
P/E
26.2x
Forward P/E
17.9x
PEG
4.6x
P/S
1.6x
P/FCF
9.5x
EV/EBITDA
15.2x
ROIC
15.3%
Gross margin
24.6%
Net margin
6.0%
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
-1.0x
Beta
1.02
Free float
91.5%

About the company

Progyny, Inc. (Progyny) is an American company specializing in providing specialized services in the field of reproductive health. The company offers a range of programs and services for couples and individuals seeking assistance with reproductive issues, including infertility treatment. Progyny focuses on supporting and coordinating treatment, which may include assisted reproduction, in vitro fertilization (IVF), and other methods. Their goal is to help people achieve healthy pregnancies and families. Progyny, Inc. shares may be suitable for investors seeking opportunities in the healthcare and reproductive health sector.

Sector

Healthcare

Industry

Medical - Healthcare Plans

CEO

Pete Anevski

Employees

846

Headquarters

New York City

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

Financial health

Can it carry its debt?

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.